| Potently neutralizing and protective human antibodies against SARS-CoV-2 SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ... Nature 584 (7821), 443-449, 2020 | 1046 | 2020 |
| Modified mRNA vaccines protect against Zika virus infection JM Richner, S Himansu, KA Dowd, SL Butler, V Salazar, JM Fox, ... Cell 168 (6), 1114-1125. e10, 2017 | 877 | 2017 |
| SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function ES Winkler, AL Bailey, NM Kafai, S Nair, BT McCune, J Yu, JM Fox, ... Nature immunology 21 (11), 1327-1335, 2020 | 827 | 2020 |
| A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies AO Hassan, JB Case, ES Winkler, LB Thackray, NM Kafai, AL Bailey, ... Cell 182 (3), 744-753. e4, 2020 | 515 | 2020 |
| A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 AO Hassan, NM Kafai, IP Dmitriev, JM Fox, BK Smith, IB Harvey, RE Chen, ... Cell 183 (1), 169-184. e13, 2020 | 492 | 2020 |
| Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice G Sapparapu, E Fernandez, N Kose, B Cao, JM Fox, RG Bombardi, ... Nature 540 (7633), 443-447, 2016 | 401 | 2016 |
| Mxra8 is a receptor for multiple arthritogenic alphaviruses R Zhang, AS Kim, JM Fox, S Nair, K Basore, WB Klimstra, R Rimkunas, ... Nature 557 (7706), 570-574, 2018 | 342 | 2018 |
| Broadly neutralizing alphavirus antibodies bind an epitope on E2 and inhibit entry and egress JM Fox, F Long, MA Edeling, H Lin, MKS van Duijl-Richter, RH Fong, ... Cell 163 (5), 1095-1107, 2015 | 205 | 2015 |
| A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection N Kose, JM Fox, G Sapparapu, R Bombardi, RN Tennekoon, AD De Silva, ... Science immunology 4 (35), eaaw6647, 2019 | 188 | 2019 |
| Brief report: chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis JJ Miner, HX Aw Yeang, JM Fox, S Taffner, ON Malkova, ST Oh, AHJ Kim, ... Arthritis & rheumatology 67 (5), 1214-1220, 2015 | 183 | 2015 |
| Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice JB Case, PW Rothlauf, RE Chen, NM Kafai, JM Fox, BK Smith, S Shrihari, ... Cell host & microbe 28 (3), 465-474. e4, 2020 | 180 | 2020 |
| A potently neutralizing antibody protects mice against SARS-CoV-2 infection WB Alsoussi, JS Turner, JB Case, H Zhao, AJ Schmitz, JQ Zhou, RE Chen, ... The Journal of Immunology 205 (4), 915-922, 2020 | 180 | 2020 |
| Isolation and characterization of broad and ultrapotent human monoclonal antibodies with therapeutic activity against chikungunya virus SA Smith, LA Silva, JM Fox, AI Flyak, N Kose, G Sapparapu, ... Cell host & microbe 18 (1), 86-95, 2015 | 150 | 2015 |
| Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans KB Yates, P Tonnerre, GE Martin, U Gerdemann, R Al Abosy, ... Nature immunology 22 (8), 1020-1029, 2021 | 143 | 2021 |
| Neutralizing monoclonal antibodies block chikungunya virus entry and release by targeting an epitope critical to viral pathogenesis J Jin, NM Liss, DH Chen, M Liao, JM Fox, RM Shimak, RH Fong, ... Cell reports 13 (11), 2553-2564, 2015 | 105 | 2015 |
| Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement G Lofano, MJ Gorman, AS Yousif, WH Yu, JM Fox, AS Dugast, ... Science immunology 3 (26), eaat7796, 2018 | 87 | 2018 |
| Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes P Pal, JM Fox, DW Hawman, YJS Huang, I Messaoudi, C Kreklywich, ... Journal of virology 88 (15), 8213-8226, 2014 | 83 | 2014 |
| Interferon lambda upregulates IDO1 expression in respiratory epithelial cells after influenza virus infection JM Fox, JM Crabtree, LK Sage, SM Tompkins, RA Tripp Journal of interferon & cytokine research 35 (7), 554-562, 2015 | 82 | 2015 |
| Immune-mediated protection and pathogenesis of chikungunya virus JM Fox, MS Diamond The Journal of Immunology 197 (11), 4210-4218, 2016 | 75 | 2016 |
| Pathogenic chikungunya virus evades B cell responses to establish persistence DW Hawman, JM Fox, AW Ashbrook, NA May, KMS Schroeder, ... Cell reports 16 (5), 1326-1338, 2016 | 75 | 2016 |
